InvestorsHub Logo
icon url

rocketeer357

10/20/07 2:18 AM

#7 RE: b9molecule #6

At worst, this company is break-even with their existing product line. Factor in FDA approval this past week and there's room to run.

All it takes is one blockbuster Q and Derma will be scooped by a major player.